CIK 0001850119 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Century Therapeutics, Inc.
Sign in to watch- Ticker
- IPSC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842040295
- Phone
- 215-981-4000
- Business address
- 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,212
- in 5 filings
Net −$10,212. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-01 | Cowan Chad Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +446,250 | 446,250 | ||
| 2024-09-12 | Quimi Daphne Director | Purchase | +5,000 | $1.53 | $8K | 5,000 |
| 2024-08-05 | Farid Adrienne Chief Operations Officer | Sale | −1,073 | $1.83 | $2K | 136,163 |
| 2024-08-05 | Carr Douglas SVP Finance & Operations | Sale | −289 | $1.83 | $528 | 334,041 |
| 2024-07-26 | Russotti Gregory See Remarks | Sale 10b5-1 | −586 | $2.50 | $1K | 274,933 |
| 2024-07-24 | Russotti Gregory See Remarks | Sale 10b5-1 | −1,600 | $2.52 | $4K | 275,519 |
| 2024-07-23 | Russotti Gregory See Remarks | Sale 10b5-1 | −200 | $2.50 | $500 | 277,119 |
| 2024-06-20 | Russotti Gregory See Remarks | Sale 10b5-1 | −5,000 | $2.84 | $14K | 277,319 |
| 2024-06-20 | JIMENEZ JOSEPH Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2024-06-20 | Walbert Timothy P Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2024-06-20 | Quimi Daphne Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2024-06-20 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2024-06-20 | Riva Alessandro Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2024-06-20 | Carlo Rizzuto Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2024-06-20 | Blackwell Kimberly Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2024-06-07 | Carr Douglas SVP Finance & Operations | Grant or award | +17,007 | 334,330 | ||
| 2024-06-05 | Russotti Gregory See Remarks | Sale 10b5-1 | −5,000 | $3.00 | $15K | 282,319 |
| 2024-05-20 | Russotti Gregory See Remarks | Sale 10b5-1 | −5,000 | $3.00 | $15K | 287,319 |
Page 6 of 6 · 118 trades